Acute venous thromboembolism in patients with brain cancer: clinical course.

ABSTRACT:

Background

Patients with brain cancer have been excluded or were underrepresented in studies on the treatment of venous thromboembolism (VTE), mainly due to the fear of intracranial hemorrhage (ICH).

Objectives

The aim of this study was to provide data on the risk of ICH, recurrent VTE, and major bleeding in patients with active brain cancer.

Methods

This was a multicenter, international cohort study at participating sites of the Registro Informatizado Enfermedad Tromboembólica Registry. Patients included in this study were classified as having known active brain cancer, active nonbrain cancer, or without active cancer. ICH at 3 months was the primary study outcome.

Results

Overall, 98,377 patients with VTE were included: 616 with active brain cancer, 16,807 wi

SUBMITTER: Becattini C 

PROVIDER: S-EPMC10551887 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature